Premier Diagnostic Health Services Inc. Announces Exercise of Share Purchase Warrants

BURNABY, BRITISH COLUMBIA--(Marketwired - Oct. 23, 2014) - Premier Diagnostic Health Services Inc. ("Premier" or the "Company") PDH announces that it has received notices of warrant exercise from certain warrantholders ("Warrantholders") that they wish to exercise their share purchase warrants into Common shares of the Company. Total proceeds of the warrant exercise are $459,844.25. A total of 9,196,885 Common shares are issuable upon the exercise. All the Warrantholders are insiders of the Company.

About Premier Diagnostic Health Services Inc. ("PDHS")

PDHS is a Canadian company that provides, through its subsidiaries, advanced medical diagnostic tools using PET/CT technology and/or MRI technology and related diagnostic skills in Canada and in the People's Republic of China, in partnership with local medical professionals, public and private investors, hospitals and clinics.

On behalf of the Board of Directors

Sanjeev Parsad President, CEO and Director

The Canadian Stock Exchange (CSE) has not reviewed the adequacy or the accuracy of the contents of this document. Company information can be viewed here: www.cnsx.ca. Further information regarding the Company can be found on SEDAR at ww.sedar.com. Not for dissemination in the United States of America.

FOR FURTHER INFORMATION PLEASE CONTACT:
Premier Diagnostic Health Services Inc.
Sanjeev Parsad
President and CEO
(604) 678.9115 or Cell: (604) 612.3965
(604) 678.9279 (FAX)
sparsad@premierdiagnostics.ca
www.premierdiagnostics.ca